Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SARS-CoV-2 Virus Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06784739
What this trial is testing

COMMUNITY - the COVID-19 Immunity Study

Who this might be right for
COVID 19Respiratory Synctial VirusInfluenza Virus+1 more
Danderyd Hospital 5,500
Testing effectiveness (Phase 2)Study completedNCT05519839
What this trial is testing

Evaluate the Safety and Immunogenicity of COVID-19 and Influenza Combination Vaccine

Who this might be right for
COVID-19Influenza
Novavax 1,579
Not applicableStudy completedNCT05268939
What this trial is testing

Performance Evaluation of LumiraDx SARS-CoV-2, Flu A/B, and RSV Tests for COVID-19 Assessment

Who this might be right for
COVID-19Influenza AInfluenza Type B+1 more
LumiraDx UK Limited 589
Not applicableUnknownNCT05682612
What this trial is testing

Prognostic Value of PtcO2 in Patients With COVID-19

Who this might be right for
COVID-19 Acute Respiratory Distress Syndrome
Southeast University, China 40
Not applicableStudy completedNCT04508972
What this trial is testing

The VOICE-COVID-19

Who this might be right for
Covid19
McGill University Health Centre/Research Institute of the McGill University Health Centre 267
Not applicableStudy completedNCT04364828
What this trial is testing

NGS Diagnostic in COVID-19 Hosts - Genetic Cause Relating to the Course of Disease Progression

Who this might be right for
COVID-19
University Hospital Tuebingen 1,000
Testing effectiveness (Phase 2)UnknownNCT04346797
What this trial is testing

CORIMUNO19-ECU: Trial Evaluating Efficacy and Safety of Eculizumab (Soliris) in Patients With COVID-19 Infection, Nested in the CORIMUNO-19 Cohort

Who this might be right for
SARS-CoV-2COVID19
Assistance Publique - Hôpitaux de Paris 120
Large-scale testing (Phase 3)Study completedNCT04452318
What this trial is testing

COVID-19 Study Assessing the Efficacy and Safety of Anti-Spike SARS CoV-2 Monoclonal Antibodies for Prevention of SARS CoV-2 Infection Asymptomatic in Healthy Adults and Adolescents Who Are Household Contacts to an Individual With a Positive SARS-CoV-2 RT-PCR Assay

Who this might be right for
Healthy Participants
Regeneron Pharmaceuticals 3,303
Not applicableStudy completedNCT04415359
What this trial is testing

Evaluation of the Evolution of Pregnancies in the First Trimester Following MAR Management During a COVD-19 Pandemic Period

Who this might be right for
Covid-19
University Hospital, Strasbourg, France 700
Not applicableStudy completedNCT05614427
What this trial is testing

The LAVA (Lateral Flow Antigen Validation and Applicability) 2 Study for COVID-19

Who this might be right for
SARS-CoV-2 Infection
Alder Hey Children's NHS Foundation Trust 449
Not applicableStudy completedNCT04591873
What this trial is testing

Using Telemedicine to Optimize Teamwork and Infection Control of Critical and Highly-infectious Patients in an Emergency Department

Who this might be right for
Critical IllnessInfections, RespiratoryEmergency Service, Hospital+1 more
National Taiwan University Hospital 74
Not applicableUnknownNCT06033560
What this trial is testing

The Effect of Non-invasive Respiratory Support on Outcome and Its Risks in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2)-Related Hypoxemic Respiratory Failure

Who this might be right for
COVID-19Hypoxemic Respiratory Failure
Amsterdam UMC, location VUmc 6,000
Not applicableStudy completedNCT05501288
What this trial is testing

Huashi Baidu Granule in the Treatment of Pediatric Patients With Mild Coronavirus Disease 2019

Who this might be right for
Coronavirus Disease 2019
Shanghai Children's Medical Center 108
Not applicableStudy completedNCT04343053
What this trial is testing

Pro-thrombotic Status in Patients with SARS-Cov-2 Infection

Who this might be right for
Severe Acute Respiratory Syndrome Coronavirus 2
University Hospital of Ferrara 145
Early research (Phase 1)Study completedNCT05260437
What this trial is testing

Safety, Reactogenicity, and Immunogenicity Trial of CV2CoV mRNA Vaccine Against SARS-CoV-2 in Seropositive Adult Participants

Who this might be right for
COVID-19SARS-CoV-2
GlaxoSmithKline 99
Testing effectiveness (Phase 2)WithdrawnNCT05018975
What this trial is testing

Tazemetostat for the Treatment of Moderate to Severe COVID-19 Infection

Who this might be right for
COVID-19 Acute Respiratory Distress SyndromeCytokine Release Syndrome
Loma Linda University
Large-scale testing (Phase 3)Study completedNCT04439045
What this trial is testing

Efficacy and Safety of VPM1002 in Reducing SARS-CoV-2 (COVID-19) Infection Rate and Severity

Who this might be right for
SARS-CoV-2 Infection
University Health Network, Toronto 122
Not applicableStudy completedNCT04919031
What this trial is testing

Inspiratory Muscle Trainer and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) COVID-19 Persistent Symptoms

Who this might be right for
Covid19HypertensionCorona Persistent Symptoms
Cairo University 90
Large-scale testing (Phase 3)Study completedNCT04652102
What this trial is testing

A Phase 2b/3, Randomized, Observer-Blinded, Placebo-Controlled, Multicenter Clinical Study Evaluating the Efficacy and Safety of Investigational SARS-CoV-2 mRNA Vaccine CVnCoV in Adults 18 Years of Age and Older

Who this might be right for
Covid19SARS-CoV-2
CureVac 39,680
Testing effectiveness (Phase 2)Ended earlyNCT04347226
What this trial is testing

Anti-Interleukin-8 (Anti-IL-8) for Patients With COVID-19

Who this might be right for
Solid TumorSars-CoV2Hematological Malignancy
Columbia University 43
Next Page